Confluence Investment Management LLC decreased its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 2.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 466,994 shares of the company’s stock after selling 14,048 shares during the quarter. Confluence Investment Management LLC owned 0.97% of Avanos Medical worth $20,426,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of AVNS. US Bancorp DE boosted its holdings in Avanos Medical by 6.7% in the third quarter. US Bancorp DE now owns 5,365 shares of the company’s stock valued at $178,000 after purchasing an additional 339 shares during the last quarter. Eudaimonia Partners LLC acquired a new stake in Avanos Medical during the third quarter worth about $51,000. Allstate Corp lifted its holdings in Avanos Medical by 3.6% in the fourth quarter. Allstate Corp now owns 12,287 shares of the company’s stock valued at $564,000 after acquiring an additional 426 shares during the period. Nisa Investment Advisors LLC boosted its position in Avanos Medical by 8.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 5,930 shares of the company’s stock worth $272,000 after purchasing an additional 450 shares in the last quarter. Finally, First Trust Advisors LP grew its stake in shares of Avanos Medical by 7.7% during the 4th quarter. First Trust Advisors LP now owns 8,925 shares of the company’s stock worth $409,000 after purchasing an additional 635 shares during the period. Hedge funds and other institutional investors own 94.80% of the company’s stock.
Shares of AVNS traded down $0.69 during mid-day trading on Thursday, hitting $42.90. 113,033 shares of the company were exchanged, compared to its average volume of 246,675. The stock has a market cap of $2.06 billion, a price-to-earnings ratio of 147.93, a price-to-earnings-growth ratio of 6.50 and a beta of 1.12. Avanos Medical, Inc. has a 1-year low of $24.71 and a 1-year high of $53.61. The company has a 50 day moving average of $46.03 and a 200-day moving average of $43.62. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.14 and a current ratio of 3.16.
Avanos Medical (NYSE:AVNS) last posted its quarterly earnings data on Wednesday, February 17th. The company reported $0.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.06. The company had revenue of $185.00 million during the quarter, compared to analyst estimates of $183.77 million. Avanos Medical had a return on equity of 3.20% and a net margin of 1.93%. Research analysts anticipate that Avanos Medical, Inc. will post 0.73 earnings per share for the current fiscal year.
A number of research firms have recently commented on AVNS. Zacks Investment Research cut Avanos Medical from a “hold” rating to a “sell” rating and set a $50.00 target price on the stock. in a research report on Wednesday, January 27th. Morgan Stanley raised their price objective on Avanos Medical from $36.00 to $45.00 and gave the company an “underweight” rating in a report on Tuesday, December 15th. Finally, KeyCorp upped their target price on Avanos Medical from $47.00 to $55.00 and gave the stock an “overweight” rating in a research note on Friday, January 8th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $45.00.
Avanos Medical Profile
Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.
See Also: What is the Current Ratio?
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.